DPP4 and diabetic kidney disease: DPP-4 inhibitors are effective in controlling blood glucose levels, have a low risk of hypoglycemia, are well tolerated in patients with T2D and diabetic kidney disease (DKD), and are expected to reduce the progression of diabetic nephropathy.